Advertisement

Topics

CardioFocus, Inc. Company Profile

12:42 EST 21st November 2017 | BioPortfolio


News Articles [9 Associated News Articles listed on BioPortfolio]

3 studies launched to assess CardioFocus' HeartLight ablation system

CardioFocus said three studies that will enroll a total of more than 1,000 participants have been initiated for assessing the -More- 

EU OKs CardioFocus' atrial fibrillation balloon

European regulators gave CardioFocus CE mark approval for its HeartLight Excalibur balloon, a device intended for treating at -More- 

CardioFocus' endoscopic ablation system wins Japanese approval for Afib

The Japanese Ministry of Health, Labor and Welfare has granted CardioFocus approval for its HeartLight endoscopic ablation sy -More- 

CardioFocus wins CE mark for next generation HeartLight Excalibur Balloon to treat AF

Medical devices maker CardioFocus has secured CE mark approval for its next-generation HeartLight Excalibur Balloon to treat atrial fibrillation (AF).

CardioFocus Receives Approval For HeartLight Endoscopic Ablation System From The

  Life Sciences Jobs   ...

CardioFocus Announces Initiation Of Three Major Studies Featuring The HeartLight System For The Treatment Of Atrial Fibrillation

  Life Sciences Jobs   ...

CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation

  Life Sciences Jobs   ...

CardioFocus® Announces European CE Mark Approval Of The Next-Generation HeartLight® Excalibur Balloon™ Designed For The Treatment Of Atrial Fibrillation

MARLBOROUGH, Mass., Sept. 27, 2017 /PRNewswire/ -- CardioFocus, Inc. today announced the European CE Mark approval of the HeartLight Excalibur Balloon, a next-generation technology desi...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CFEAS- AC) for the Treatment of Symptomatic Atrial Fibrillation

The purpose of this study is to determine the safety and effectiveness of the endoscopic ablation system - adaptive contact (EAS-AC) in treated paroxysmal atrial fibrillation (PAF) with pu...

Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation

This is a demonstration of safety and efficacy of the ablation for pulmonary vein isolation in the treatment of paroxysmal atrial fibrillation.

Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)

The purpose of this study is to demonstrate the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact (HeartLight) in the treatment of atrial fibrill...

CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation

The aim of the study is to compare the acute procedure and safety outcomes as well as long term clinical outcomes of 2 groups of patients treated with the HeartLight® Endoscopically Guide...

Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs

The purpose of the study is to compare two types of treatment for atrial fibrillation (AF) that are designed to treat the symptoms of atrial fibrillation. The treatments being compared ar...

More Information about "CardioFocus, Inc." on BioPortfolio

We have published hundreds of CardioFocus, Inc. news stories on BioPortfolio along with dozens of CardioFocus, Inc. Clinical Trials and PubMed Articles about CardioFocus, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CardioFocus, Inc. Companies in our database. You can also find out about relevant CardioFocus, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record